Gene Query: MRPS30

Dataset Description Geneva Score
Cleavage Factor Im as a key regulator of 3’ UTR length 30.42
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 27.76
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 22.64
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 19.24
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 18.54
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 18.54
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 18.5
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 18.5
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 17.84
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 17.27
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 15.75
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 15.7
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 15.42
CD73 knockdown effect in pancreatic cancer cell lines 14.74
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 14.18
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 14.08
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 13.84
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 13.84
Region-specific Innate Antiviral Responses of the Human Epididymis 13.58
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 13.56
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 13.46
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 13.32
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 13.12
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 13.09
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 13.09
Role of microRNAs in the interaction between Salmonella and the host cell 12.76
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 12.73
An RNA-centric dissection of host complexes controlling flavivirus infection 12.73
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 12.7
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 12.59
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 12.49
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 12.48
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 12.48
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 12.39
A practical evaluation of alignment algorithms for RNA variant calling analysis 12.37
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 12.3
Seletive inhibition of CDK9 in DLBCL cell lines 12.24
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 12.18
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 12.18
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 11.64
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 11.61
KLF6-dependent transcription in renal cancer cells 11.19
TGF-β regulation of miRNA expression in pancreatic cancer 11.06
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 10.7
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 10.34
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 10.16
Effect of drugs on transcriptomic profiles 10.07
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 9.87
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 9.79
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 9.66
SLAM-seq for K562 endogenous mRNA decay 9.36
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 9.31
The landscape of alternative splicing in aggressive prostate cancers 9.24
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 9.23
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 9.21
Developmental stage specific chromosome architecture in human erythroid cells 8.97
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 8.97
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 8.91
Sensing self and nonself circular RNAs 8.85
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 8.75
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 8.67
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 8.62
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 8.61
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 8.61
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 8.54
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 8.42
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 8.42
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 8.39
Tracking distinct RNA populations using efficient and reversible covalent chemistry 8.38
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 8.33
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 8.31
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 8.27
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 8.17
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 8.06
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 7.93
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 7.93
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 7.9
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 7.89
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 7.89
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 7.89
Peptidomimetic blockade of MYB in acute myeloid leukemia 7.89
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 7.81
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 7.81
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 7.69
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 7.68
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 7.68
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 7.67
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 7.63
MARS Seq data from human cortical organoids 7.62
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 7.56
MYC dependent mRNA translation shapes gene expression and cell biology 7.55
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 7.47
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 7.37
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 7.32
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 7.32
RNA sequencing of matched nephrectomy samples [RNA-seq] 7.26
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 7.26
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 7.23
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 7.22
RNA-seq melanoma 7.19
RNA-seq of human aneuploid cell lines with Trisomy 21 7.14
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 7.06
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 7.06
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 7.04
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 7.04
Transcriptome analysis of U87 cells upon LINC00152 knockdown 6.86
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 6.84
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 6.82
RNA-Seq with and without RNase treatment in PCa cell lines 6.74
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 6.74
RNA-seq data from human lymphoma cell lines 6.73
ChIP-seq and RNA-seq from human lymphoma cell lines 6.73
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 6.73
Differential gene expression of human melanoma cells [RNA-seq] 6.73
snRNAs as regulators of alternative splicing 6.73
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 6.72
RNA-seq analysis of control and Myc-induced U2OS cells 6.68
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 6.67
ARID1A regulates condensin II distribution and chromosomal partition 6.67
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 6.65
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 6.62
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 6.59
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 6.55
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 6.54
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 6.53
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 6.51
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 6.45
Global analysis of enhancer targets: Mosaic-seq 6.42
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 6.41
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 6.36
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 6.35
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 6.32
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 6.32
PNET animal model: new insights (II) 6.3
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 6.29
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 6.28
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 6.19
Genome-wide discovery of human splicing branchpoints [RNAse] 6.14
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 6.13
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 6.1
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 6.08
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 6.08
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 6.08
Mitochondrial dsRNA triggers antiviral signalling in humans 6.03
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 5.98
Human embryonic stem cells in E8 and AKIT culture medium 5.98
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 5.96
TCF7L1 knockdown in pancreatic cancer 5.93
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 5.88
Transcriptome analysis upon C6orf203 silencing 5.86
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 5.85
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 5.85
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 5.78
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 5.78
RNA-seq analysis of differentiating human erythroblasts 5.77
LNCaP treated with iBET 5.77
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 5.77
Role of XRN2 ribonucleolytic activity in RNA metabolism 5.74
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 5.73
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 5.73
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 5.72
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 5.68
FBXW7 modulates stress response by post-translational modification of HSF1 5.68
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 5.66
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 5.64
Gene expression profile in breast cancer cells 5.64
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 5.59
4sUDRB-seq: measuring transcription elongation and initiation genomewide 5.59
A map of gene expression in neutrophil-like cell lines 5.57
Tracking of dCas9-methyltransferase footprints 5.54
Single-nucleotide-resolution mapping of HBV promoters using CAGE 5.53
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 5.52
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 5.51
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 5.5
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 5.49
RNAseq in Alzheimer's Disease patients 5.47
Identification of Nrf2 regulated genes by RNA sequencing 5.47
Nrf2 regulated genes in A549 cells 5.47
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 5.47
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 5.46
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 5.46
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 5.43
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 5.41
Overexpression of NFIB and YBX1 in MCF-7 cells 5.4
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 5.35
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 5.34
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.34
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 5.3
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 5.29
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 5.29
Gene expression analysis of the impact of TDP-43 knockout in human cells. 5.28
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 5.23
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 5.23
Genome wide expression change by RNF168 knocking down in NEC cells 5.21
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 5.21
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 5.21
An acquired vulnerability of drug resistant melanoma with therapeutic potential 5.21
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 5.14
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 5.14
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 5.14
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 5.11
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 5.1
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 5.1
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 5.1
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 5.1
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 5.09
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 5.06
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 5.05
Gene expression signatures of innate lymphoid cells from human blood 5.04
MYCL and EP400 are required for Max and MCPyV mediated gene activation 5.02
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 5.01
RNA sequencing of primary human platelets and in vitro cell lines 5.0
High-throughput sequencing of PROMPT-enriched samples. 5.0
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 4.99
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 4.96
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 4.92
Cerebellar differentiation in Ataxia-Telangiectasia 4.88
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 4.88
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 4.88
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 4.88
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 4.85
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 4.85
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 4.83
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 4.83
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 4.82
Comprehensive comparative analysis of 5’ end RNA sequencing methods 4.77
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 4.77
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 4.75
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 4.72
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 4.72
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 4.72
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 4.71
Transcriptomic analyssis following EHMT1/2 inhibition 4.7
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 4.7
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 4.69
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 4.69
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 4.68
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 4.64
RNA-seq analysis of AML cells in response to ASLAN003 4.61
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 4.6
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 4.59
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 4.59
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 4.58
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 4.54
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 4.53
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 4.53
Effect of PBK knockdown on C4-2 cell transcriptome 4.52
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 4.51
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 4.51
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 4.5
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 4.49
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 4.46
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 4.46
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 4.43
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 4.42
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 4.42
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 4.4
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 4.4
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 4.34
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 4.34
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 4.34
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 4.34
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 4.31
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 4.3
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 4.28
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 4.27
Identification of HOXB13 target genes responsive to BET inhibitors 4.26
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 4.25
The cohesin complex prevents Myc-induced replication stress 4.25
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 4.23
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 4.23
Gene expression in GBM with Cav3.2 inhibition 4.22
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 4.2
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 4.15
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 4.14
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 4.1
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 4.04
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 4.04
Transcriptomic analysis of the HOTAIR-regulated genes 4.02
Transcriptomic analysis of ERR alpha orphan nuclear receptor 4.0
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 3.99
Capturing the Interactome of Newly Transcribed RNA (RICK) 3.99
Capturing the Interactome of Newly Transcribed RNA 3.99
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 3.96
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 3.95
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 3.94
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 3.9
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 3.9
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 3.89
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 3.84
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 3.84
Total RNA-seq in ALL-SIL upon TLX1 knockdown 3.84
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.81
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 3.77
RNA seq with AML (NB4) cells upon FTO inhibition 3.73
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 3.68
RNA-Seq of PRMT1 overexpression ECA109 cells 3.68
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 3.63
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.59
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 3.58
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 3.57
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 3.57
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 3.57
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.53
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 3.53
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 3.52
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 3.52
Knockdown of ADNP in HCT116 colon cancer cells 3.5
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 3.49
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 3.44
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 3.43
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 3.42
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 3.36
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 3.36
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 3.35
Global epigenomic reconfiguration during mammalian brain development 3.34
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 3.33
scRNASeq analysis of cycling cardiomyocytes 3.33
LIN28A Over-expression RNAseq 3.31
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 3.3
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 3.3
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.27
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 3.27
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 3.25
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 3.25
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 3.25
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.25
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 3.18
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 3.18
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.14
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 3.11
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 3.1
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 3.09
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 3.09
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 3.06
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 3.06
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 3.05
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 3.04
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 3.03
m6A-dependent regulation of messenger RNA stability 3.02
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.99
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 2.98
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 2.98
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.96
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 2.94
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 2.94
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 2.93
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 2.93
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 2.89
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 2.86
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 2.76
Gene expression changes caused by KRAS in MCF-10A 2.74
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.74
p53 activity results in DNA replication fork processivity 2.73
Role of COP1 on MAP kinase transcriptional output in melanoma 2.7
Illumina HiSeq Sequencing on Breast cancer PDX samples 2.67
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.67
Real-time observation of light-controlled transcription in living cells 2.65
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 2.64
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 2.63
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 2.62
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 2.61
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 2.61
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 2.61
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 2.59
N6-methyladenine DNA Modification in Glioblastoma 2.54
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 2.54
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 2.54
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 2.51
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 2.51
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 2.48
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.45
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 2.45
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 2.41
SETBP1-WT and SETBP1-G870S epigenetic landscapes 2.41
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.37
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.37
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 2.36
Interaction between mitoNEET and NAF-1 in cancer cells 2.35
hnRNP C is a key regulator of protein synthesis in mitosis 2.33
O-glcnAc reprograms cellular energetics 2.27
K562 polyA RNA-Seq 2.18
The age and genomic integrity of neurons after cortical stroke in humans 2.17
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 2.15
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 2.13
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 2.11
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 2.1
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.07
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 2.07
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 2.07
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.06
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.06
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.05
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 2.0
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.94
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.94
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.94
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 1.94
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 1.89
Effects of a nutritional supplement in older individuals subject to ten days of complete bed rest. 1.89
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 1.83
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 1.83
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.83
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.82
MAIT cell RNA sequencing 1.82
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 1.81
mRNA-sequencing of breast cancer subtypes and normal tissue 1.79
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.78
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 1.77
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 1.74
EWS-Fli and LNC regulated genes in comparison to GFP samples 1.74
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.73
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 1.73
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.73
RNA sequencing analysis of selumetinib-resistant CRC cells lines 1.72
Functional significance of the HIV-1 Tat signature amino acid residues 1.66
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 1.62
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 1.6
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 1.59
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.57
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 1.56
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 1.56
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.55
Differential gene expression profiles in imatinib-resistant cell lines 1.54
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 1.53
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 1.52
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 1.52
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 1.49
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 1.47
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.44
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.43
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 1.4
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 1.36
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 1.34
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 1.31
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 1.31
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.26
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 1.22
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 1.19
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 1.19
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.09
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.08
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.06
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 1.03
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 0.99
Discovering human diabetes-risk gene function with genetics and physiological assays 0.94
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 0.94
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 0.9
Dilated cardiomyopathy vs Myocarditis 0.9
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.88
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.88
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.87
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.87
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.82
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.8
Modeling Human Cancer-induced Cachexia (Human) 0.8
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.79
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.79
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 0.78
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.78
HBEC-shp53-PCHD7 0.77
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 0.77
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 0.76
Impact on erythroid progenitor type on erythroid differntiation 0.76
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.75
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.72
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.71
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 0.68
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.67
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.65
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.65
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 0.62
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 0.59
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.58
nELAVL HITS-CLIP in Alzheimer's Disease patients 0.51
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.5
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 0.46
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.43
Microprocessor mediates transcription termination in long noncoding microRNA genes 0.41
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.38
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.38
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 0.34
MARCKS and lnc-MARCKS act as inflammation regulators 0.32
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 0.27
Iron response of HepG2 cells 0.26
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 0.23
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 0.22
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.22
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.19
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.17
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.17
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.13
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.13
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 0.12
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 0.11
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.07
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 0.05
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.05
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.05
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation